The FDA Ad Crackdown Has Pharma's Attention. But Companies Aren't 'Radically Changing Course'—Yet
Joanne Hawana was quoted by Endpoints News in an article about how the pharma industry continues to spend hundreds of millions of dollars on ads despite a significant FDA crackdown on misleading consumer ads.
Joanne observed that many ads may transition from TV to online which may present new benefits. "You can basically have much more information on a website. It reduces the risk of being deemed distracting or misleading, because you have more space and time."
Source